Related Experiment Video
Updated: Jul 21, 2026

06:38
An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
African iron overload and hepatocellular carcinoma (HA-7-0-080)
V M Moyo1, R Makunike, I T Gangaidzo
1Department of Medicine, University of Zimbabwe, Harare, Zimbabwe.
European Journal of Haematology
|February 6, 1998
Summary
Iron overload in Africa is linked to a 3.1 times higher risk of hepatocellular carcinoma. This finding suggests iron overload may be a significant risk factor for this liver cancer in the African population.
Area of Science:
- Hepatology
- Oncology
- Public Health
Background:
- Hereditary hemochromatosis and HLA-linked iron overload increase hepatocellular carcinoma (HCC) risk in Europeans.
- Iron overload in Africa is not traditionally linked to HCC.
- Investigating potential etiological links between African iron overload and HCC is crucial.
Purpose of the Study:
- To determine if African iron overload is associated with hepatocellular carcinoma.
- To assess the histological evidence of iron overload in liver biopsies from Zimbabwe.
Main Methods:
- Reviewed 320 liver biopsies from the University of Zimbabwe (1992-1994).
- Selected 215 adult biopsies for histological assessment of hepatocellular iron.
- Stratified subjects into normal/mild iron (0-2+) and iron overload (3+-4+) groups.
Main Results:
- Thirty-six subjects (16.7%) had hepatocellular carcinoma.
- Logistic regression showed a significant association between iron overload and HCC (p=0.041).
- Individuals with iron overload had 3.1 times higher odds of HCC compared to those without.
Conclusions:
- Iron overload may be an independent risk factor for hepatocellular carcinoma in Africa.
- Further research is needed to explore co-factors like viral hepatitis and aflatoxins.
- Findings challenge the traditional view of iron overload's role in African HCC.
Related Concept Videos
Diseases of the Liver and Gallbladder
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
Jaundice
Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...

